Introduction Dyslipidemia is a key clinical abnormality among diabetes mellitus (DM)
patients, which heightens their risk of cardiovascular events. Data on the serum lipid profile …

Abstract Introduction: Diabetes mellitus (DM), a chronic metabolic noncommunicable
disease (NCD), has assumed epidemic proportions worldwide. Type 2 diabetes (T2D) is …

Dyslipidemia Among Patients With Type 1 Diabetes and Its Associated Factors in Saudi
Arabia: An Analytical Cross-Sectional Study Page 1 Review began 02/02/2022 Review …

Objectives To determine the prevalence and patterns of dyslipidemia and its associated risk
factors among patients with type 2 diabetes attending the National Center for Diabetes …

Background Dyslipidemia is one of the major modifiable risk factors for cardiovascular
diseases (CVD) in a type-2 diabetic (T2DM) patient. Dyslipidemia in T2DM patients is …

BACKGROUND: Non-insulin dependent diabetes mellitus (type II DM) is frequently
associated with abnormal levels of lipids, particularly in patients with poor diabetic control …

Introduction: dyslipidemia confers excess atherosclerotic cardiovascular risk in type 2
diabetes mellitus (DM) patients, and this requires prompt identification and management to …

Dyslipidemia is considered a significant modifiable risk factor for type-2 diabetes mellitus
(T2DM) and has become one of the emerging health problems throughout the world. In …

Previous studies have shown that diabetes mellitus (DM) increases the risk of
cardiovascular disease in women to a greater extent than in men. It seems that DM may alter …

Background Atherogenic dyslipidemia is an important modifiable risk factor for
cardiovascular disease among patients of type 2 diabetes mellitus. Timely detection and …